Investor profile
Longview Ventures has backed 2 European tech companies across 2 funding rounds between 2024 and 2025, joining rounds totalling €138M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Antag Therapeutics | Denmark | 1 | €80M |
| haya therapeutics | Switzerland | 1 | €58M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Antag Therapeutics | Series A | €80M | 2024-12 |
| haya therapeutics | Series A | €58M | 2025-05 |
